To evaluate the role of PDK4 in bladder cancer, we suppressed PDK4 expression, and downregulated PDK4 reduced the migratory capacity and invasiveness of bladder cancer cells by modulating p-ERK, p-SRC, and p-JNK. This evidence concerns the gene MAPK1 and urinary bladder carcinoma.